Clinical Trial Update: Modified Autologous Leukocyte Cells for the Treatment of Acute Kidney Injury After Cardiac Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating modified autologous leukocyte cells for acute kidney injury following cardiac surgery; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Modified autologous leukocyte cell therapy

Snippet

Sponsor: M2RLAB SL | Conditions: Acute Kidney Injury | Phase 2 | Status: NOT_YET_RECRUITING